SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011762
Filing Date
2018-08-14
Accepted
2018-08-14 15:55:33
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 310579
2 ex31-1.htm EX-31.1 22039
3 ex31-2.htm EX-31.2 21649
4 ex32-1.htm EX-31.1 11404
  Complete submission text file 0001493152-18-011762.txt   2680832

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptix-20180630.xml EX-101.INS 465010
6 XBRL SCHEMA FILE ptix-20180630.xsd EX-101.SCH 36166
7 XBRL CALCULATION FILE ptix-20180630_cal.xml EX-101.CAL 36943
8 XBRL DEFINITION FILE ptix-20180630_def.xml EX-101.DEF 147542
9 XBRL LABEL FILE ptix-20180630_lab.xml EX-101.LAB 252828
10 XBRL PRESENTATION FILE ptix-20180630_pre.xml EX-101.PRE 206361
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 181017111
SIC: 7389 Services-Business Services, NEC
Assistant Director 2 & 3